Total
0
Shares
Oneview Healthcare (ASX:ONE) - CEO, James Fitter (left) and President & Founder, Mark McCloskey (right) - The Market Herald
CEO, James Fitter (left) and President & Founder, Mark McCloskey (right)
Source: Silicon Republic
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Oneview Healthcare (ONE) confirms the signing of Northern Health as its first Cloud Start customer in Australia
  • Oneview’s Cloud Start product enables patients to communicate with their clinicians in a covid-safe manner, using its Oneview Care Experience Platform
  • The company’s Cloud Start product will be deployed to Northern Health’s recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project, which became operational in May 2021
  • Oneview Healthcare was up 6.02 per cent, trading at 44 cents at 11:50 am AEST

Oneview Healthcare (ONE) has confirmed the signing of Northern Health as its first Cloud Start customer in Australia.

Northern Health is a provider of acute, maternity and specialist services in Melbourne’s outer north through its four main campuses, Northern Hospital Epping, Broadmeadows Hospital, Bundoora Centre, and Craigieburn Centre, in the area’s fast-growing northern growth corridor.

Oneview’s Cloud Start product will be deployed to Northern Health’s recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project, which became operational in May 2021.

Oneview’s Cloud Start product enables patients to communication with their clinicians in a covid-safe manner, using its Oneview Care Experience Platform.

The platform unifies a facility’s systems, content and services into one digital platform, with dedicated devices at the point of care. In doing so, the company says it delivers more control for patients and their families, more time for care teams, and less complexity for executives and IT teams.

The project is expected to go live in the third quarter of 2021.

Oneview Healthcare is up 4.82 per cent, trading at 43.5 cents at 11:30 am AEST.

ONE by the numbers
More From The Market Herald
Rhythm Biosciences (ASX:RHY) brings ColoSTAT trial to Queensland

" Proteomics International Laboratories (ASX:PIQ) to collaborate for world’s first endometriosis test

Proteomics International Laboratories (PIQ) has penned a research agreement to develop a non-invasive test for endometriosis.
ResApp Health (ASX:RAP) - CEO & Managing Director, Dr Tony Keating - The Market Herald

" ResApp Health (ASX:RAP) secures two deals to integrate its diagnostic test

ResApp Health (RAP) has secured two new agreements for its smartphone-based acute respiratory diagnostic test.
Paradigm Biopharmaceuticals (ASX:PAR) - Chairman & CEO, Paul Rennie - The Market Herald

" FDA requests further clarification from Paradigm Biopharmaceuticals (ASX:PAR)

The US Food and Drug Administration has requested further clarification from Paradigm Biopharmaceuticals (PAR) for its Investigational New Drug (IND) application.
Patrys (ASX:PAB) - CEO and Managing Director, Dr James Campbell - The Market Herald

" Patrys’ (ASX:PAB) clinical trials pushed back

Patrys’ (PAB) planned PAT-DX1 clinical trial will be postponed for up to six months due to global manufacturing and supply chain delays.